Anemia is managed with red blood cell transfusions and erythropoiesis-stimulating agents (ESA), with a 60% response rate, particularly in patients with low endogenous erythropoietin (EPO) levels [104]. The gene discussed is EPO; the disease is anemia (phenotype).